Ftse Mib
33.975,52
1,03%
DAX
18.182,72
1,05%
S&P 500
5.127,79
0,00%
NASDAQ
16.156,33
0,00%
Bitcoin
63.424,18
-0,90%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ MiroMatrix Medical Inc (MIRO) MiroMatrix Medical Inc (MIRO) Notizie

MiroMatrix Medical Inc

MIRO
3,39
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 02:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
26/12/202312:02EDGAR2Form 15-12G - Securities registration termination [Section..
18/12/202322:30EDGAR2Form 8-K - Current report
18/12/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
13/12/202322:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202322:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202316:14EDGAR2Form POS AM - Post-Effective amendments for registration..
13/12/202316:13EDGAR2Form S-8 POS - Securities to be offered to employees in..
13/12/202316:03EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
13/12/202315:15BWUnited Therapeutics and Miromatrix Medical Announce..
12/12/202317:22EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
12/12/202312:00BWUnited Therapeutics and Miromatrix Medical Announce..
07/12/202322:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
30/11/202323:14EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
14/11/202322:05GLOBEMiromatrix Reports Third Quarter 2023 Results
14/11/202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202313:01EDGAR2Form SC 14D9 - Solicitation, recommendation statements
30/10/202312:03EDGAR2Form SC14D9C - Written communication relating to third party..
30/10/202311:12EDGAR2Form 8-K - Current report
30/10/202311:05GLOBEUnited Therapeutics to Acquire Miromatrix Medical
30/10/202311:00BWUnited Therapeutics to Acquire Miromatrix Medical
11/10/202322:05GLOBEMiromatrix to Present at the 2023 ISODP Organ Donation..
05/10/202322:30GLOBEMiromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene..
06/9/202322:01GLOBEMiromatrix Announces Participation in H.C. Wainwright Global..
05/9/202322:04GLOBEMiromatrix Announces Participation in the ARM Tissue..
14/8/202322:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202322:01EDGAR2Form 8-K - Current report
14/8/202322:01GLOBEMiromatrix Reports Second Quarter 2023 Results and Provides..
25/7/202322:01GLOBEMiromatrix to Report Second Quarter 2023 Financial Results
13/7/202322:01GLOBEMiromatrix Poster Voted Best in Congress at the 2023..
01/6/202322:01GLOBEMiromatrix Announces CEO Jeff Ross, Ph.D. will Expand His..
30/5/202322:08GLOBEMiromatrix Presenting at the 2023 American Transplant..
30/5/202322:05GLOBEMiromatrix Announces Participation in the 20th Annual..
11/5/202322:01GLOBEMiromatrix Reports First Quarter 2023 Results and Provides..
Apertura: Min: Max:
Chiusura: 3,39

La tua Cronologia

NASDAQ
MIRO
MiroMatrix Medical
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network